{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T06:23:30Z","timestamp":1795155810083,"version":"4.10.3"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:00:00Z","timestamp":1720396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:00:00Z","timestamp":1720396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s00270-024-03799-6","type":"journal-article","created":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T20:21:54Z","timestamp":1720470114000},"page":"1239-1245","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Single-Session Ablative Transarterial Radioembolization for Patients with Hepatocellular Carcinoma to Streamline Care: An Initial Experience"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8651-9772","authenticated-orcid":false,"given":"Zachary T.","family":"Berman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Pianka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousuf","family":"Qaseem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Redmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeet","family":"Minocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,8]]},"reference":[{"issue":"6","key":"3799_CR1","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","volume":"77","author":"H Rumgay","year":"2022","unstructured":"Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J, et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022;77(6):1598\u2013606.","journal-title":"J Hepatol"},{"issue":"3","key":"3799_CR2","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","volume":"76","author":"M Reig","year":"2022","unstructured":"Reig M, Forner A, Rimola J, Ferrer-Fabrega J, Burrel M, Garcia-Criado A, et al. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. J Hepatol. 2022;76(3):681\u201393.","journal-title":"J Hepatol"},{"issue":"9","key":"3799_CR3","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S2468-1253(22)00091-7","volume":"7","author":"E Kim","year":"2022","unstructured":"Kim E, Sher A, Abboud G, Schwartz M, Facciuto M, Tabrizian P, et al. Radiation segmentectomy for curative intent of unresectable very early to early stage hepatocellular carcinoma (RASER): a single-centre, single-arm study. Lancet Gastroenterol Hepatol. 2022;7(9):843\u201350.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"3799_CR4","first-page":"2342","volume":"74","author":"R Salem","year":"2021","unstructured":"Salem R, Johnson GE, Kim E, Riaz A, Bishay V, Boucher E, et al. Yttrium-90 Radioembolization for the treatment of solitary. Unresectable HCC: The LEGACY Study Hepatology. 2021;74(5):2342\u201352.","journal-title":"Unresectable HCC: The LEGACY Study Hepatology"},{"issue":"2","key":"3799_CR5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1053\/j.tvir.2019.02.009","volume":"22","author":"A Gabr","year":"2019","unstructured":"Gabr A, Ali R, Al Asadi A, Mora R, Mouli S, Riaz A, et al. Technical aspects and practical approach toward same-day Y90 radioembolization in the management of hepatocellular carcinoma. Tech Vasc Interv Radiol. 2019;22(2):93\u20139.","journal-title":"Tech Vasc Interv Radiol"},{"issue":"6","key":"3799_CR6","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.jhep.2020.02.024","volume":"72","author":"A Gabr","year":"2020","unstructured":"Gabr A, Ranganathan S, Mouli SK, Riaz A, Gates VL, Kulik L, et al. Streamlining radioembolization in UNOS T1\/T2 hepatocellular carcinoma by eliminating lung shunt estimation. J Hepatol. 2020;72(6):1151\u20138.","journal-title":"J Hepatol"},{"issue":"7","key":"3799_CR7","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s00270-019-02371-x","volume":"43","author":"A Ezponda","year":"2020","unstructured":"Ezponda A, Rodriguez-Fraile M, Morales M, Vivas I, De La Torre M, Sangro B, et al. Hepatic flow redistribution is feasible in patients with hepatic malignancies undergoing same-day work-up angiography and Yttrium-90 microsphere radioembolization. Cardiovasc Intervent Radiol. 2020;43(7):987\u201395.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"7","key":"3799_CR8","first-page":"1209","volume":"47","author":"SA Gulec","year":"2006","unstructured":"Gulec SA, Mesoloras G, Stabin M. Dosimetric techniques in 90Y-microsphere therapy of liver cancer: the MIRD equations for dose calculations. J Nucl Med. 2006;47(7):1209\u201311.","journal-title":"J Nucl Med"},{"issue":"2","key":"3799_CR9","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-022-05956-w","volume":"50","author":"R Salem","year":"2023","unstructured":"Salem R, Padia SA, Lam M, Chiesa C, Haste P, Sangro B, et al. Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group. Eur J Nucl Med Mol Imaging. 2023;50(2):328\u201343.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"3799_CR10","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.jvir.2017.06.019","volume":"28","author":"O Khalilzadeh","year":"2017","unstructured":"Khalilzadeh O, Baerlocher MO, Shyn PB, Connolly BL, Devane AM, Morris CS, et al. Proposal of a new adverse event classification by the society of interventional radiology standards of practice committee. J Vasc Interv Radiol. 2017;28(10):1432\u20137.","journal-title":"J Vasc Interv Radiol"},{"issue":"3","key":"3799_CR11","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.amjsurg.2020.12.052","volume":"222","author":"JB Siegel","year":"2021","unstructured":"Siegel JB, Allen S, Engelhardt KE, Morgan KA, Lancaster WP. Travel distance and overall survival in hepatocellular cancer care. Am J Surg. 2021;222(3):584\u201393.","journal-title":"Am J Surg"},{"issue":"8","key":"3799_CR12","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1002\/jso.27423","volume":"128","author":"S Gholami","year":"2023","unstructured":"Gholami S, Kleber KT, Perry LM, Abidalhassan M, McFadden NR, Bateni SB, et al. Disparities in treatment and survival in early-stage hepatocellular carcinoma in California. J Surg Oncol. 2023;128(8):1302\u201311.","journal-title":"J Surg Oncol"},{"issue":"3","key":"3799_CR13","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jvir.2011.11.016","volume":"23","author":"CE Ray Jr","year":"2012","unstructured":"Ray CE Jr, Battaglia C, Libby AM, Prochazka A, Xu S, Funaki B. Interventional radiologic treatment of hepatocellular carcinoma-a cost analysis from the payer perspective. J Vasc Interv Radiol. 2012;23(3):306\u201314.","journal-title":"J Vasc Interv Radiol"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-024-03799-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00270-024-03799-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-024-03799-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T15:04:12Z","timestamp":1725635052000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00270-024-03799-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,8]]},"references-count":13,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["3799"],"URL":"https:\/\/doi.org\/10.1007\/s00270-024-03799-6","relation":{},"ISSN":["0174-1551","1432-086X"],"issn-type":[{"value":"0174-1551","type":"print"},{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,8]]},"assertion":[{"value":"10 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"ZTB has received speaking honoraria from Boston Scientific Corporation. The other authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"For this type of study, consent for publication is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"For this type of study formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}